Platelets as an inter-player between hyperlipidaemia and atherosclerosis

Area of Science:

• Cardiovascular Research
• Atherosclerosis Pathogenesis
• Lipid Metabolism

Background:

• Platelet hyperreactivity and hyperlipidaemia are key contributors to atherosclerosis.
• Native LDL (nLDL) and oxidized LDL (oxLDL) are central to hyperlipidaemia's proatherosclerotic effects.
• Understanding the platelet-lipoprotein interaction is crucial for atherogenesis research.

Purpose of the Study:

• To review the intricate relationship between platelets and lipids in the context of atherosclerosis.
• To elucidate the mechanisms by which platelet dysfunction and hyperlipidaemia interact.
• To discuss the implications for therapeutic interventions and future research.

Main Methods:

• Literature review focusing on the molecular interactions between lipoproteins and platelet receptors (e.g., LDLR, CD36).
• Analysis of platelet-mediated modulation of lipoprotein metabolism, including LDL oxidation and uptake.
• Examination of how hypolipidemic and antiplatelet drugs affect this interplay.

Main Results:

• nLDL and oxLDL bind to specific platelet receptors, inducing mild activation and priming.
• Platelets contribute to LDL oxidation and influence LDL uptake and foam cell formation.
• A bidirectional relationship exists where platelets affect lipid metabolism and vice versa.

Conclusions:

• Platelet dysfunction and hyperlipidaemia synergistically accelerate atherogenesis.
• The interplay suggests potential for combined therapeutic strategies targeting both pathways.
• Further research into this complex interaction is warranted for novel treatment development.